Volume 14, Issue 1 (January & February-In Press 2023)                   BCN 2023, 14(1): 0-0 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Olakunle Ishola A, Enitan Adetunji A, Chukwunwike Abanum I, Akorede Adeyemi A, Kenechukwu Faleye C, Babale Martins J, et al . Datumetine Preferentially Upregulates NMDAR Signalling Pathways in Different Brain Regions of Mice. BCN 2023; 14 (1)
URL: http://bcn.iums.ac.ir/article-1-2169-en.html
1- Department of Anatomy, College of Medicine and Health Sciences, Afe Babalola University Ado-Ekiti Nigeria.
2- Department of Medical Laboratory Science, College of Medicine and Health Sciences, Afe Babalola University Ado-Ekiti Nigeria.
3- Department of Anatomy, College of Health Technology Ijero-Ekiti, Nigeria.
4- Department of Anatomy, University of Ilorin, Ilorin Nigeria.
Background: We earlier reported that datumetine possesses binding affinity with NMDAR and that 14-day exposure to datumetine altered NMDAR signalling by mimicking glutamate toxicity. Here, we investigated the potential neuroprotective effect of a single shot of a low dose of datumetine administration in BALB/c mice.
Results: Relative to Veh, datumetine downregulate the expression of CamKIIα in the hippocampus and PFC but not in the cerebellum, CREB was also upregulated in the PFC only, but pCREB was also upregulated in all the three brain regions observed, while BDNF was only upregulated in both hippocampus and PFC of Datumetine relative to Veh. MK-801 on the other hand reversed some of the effects of datumetine in the brain regions observed. No major histological alterations were observed in the different brain regions immunohistochemically.
Conclusion: We conclude that a single low dose of datumetine moderately enhances NMDAR activity. This showed the neuroprotective potentials of low datumetine exposure.
Type of Study: Original | Subject: Behavioral Neuroscience
Received: 2021/05/13 | Accepted: 2021/06/30 | Published: 2023/01/12

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb